A nonfibrin macromolecular cofactor for tPA-mediated plasmin generation following cellular injury

Blood

Volumn 114, Issue 9, 2009, Pages 1937-1946

  Samson, Andre L ^a   Borg, Rachael J ^a   Niego, Be'eri ^a   Wong, Connie H Y ^b   Crack, Peter J ^b   Tang, Yongqing ^a   Medcalf, Robert L ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; PLASMIN; PLASMINOGEN; PROTEINASE; TISSUE PLASMINOGEN ACTIVATOR; FIBRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DAMAGE; CELL TYPE; CELL VIABILITY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE ASSOCIATION; EX VIVO STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROMOLECULE; MALE; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN DEGRADATION; RAT; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CELL CULTURE; CELL LINE; CHEMISTRY; ISCHEMIA; METABOLISM; PATHOLOGY; STROKE;

ANIMALS; CELL LINE; CELLS, CULTURED; FIBRIN; ISCHEMIA; MACROMOLECULAR SUBSTANCES; MALE; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; NEURONS; PLASMIN; RATS; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 70349232897     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-02-203448     Document Type: Article

References (58)

1. Madison EL, Coombs GS, Corey DR. Substrate specificity of tissue type plasminogen activator: characterization of the fibrin independent specificity of t-PA for plasminogen. J Biol Chem.1995;270(13):7558-7562.
2. Kwon M, Macleod TJ, Zhang Y, Waisman DM. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors. Front Biosci. 2005;10:300-325. (Pubitemid 40543035)
3. Collen D, Lijnen HR. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood. 1991;78(12):3114-3124.
4. Cesarman-Maus G, Hajjar KA. Molecular mechanisms of fibrinolysis. Br J Haematol. 2005;129(3):307-321.
5. Akiyama H, Tooyama I, Kondo H, et al. Early response of brain resident microglia to kainic acid-induced hippocampal lesions. Brain Res. 1994;635(1-2):257-268. (Pubitemid 24031412)
6. Okada Y, Copeland BR, Fitridge R, Koziol JA, del Zoppo GJ. Fibrin contributes to microvascular obstructions and parenchymal changes during early focal cerebral ischemia and reperfusion. Stroke. 1994;25(9):1847-1853. (Pubitemid 24274983)
7. Tabrizi P, Wang L, Seeds N, et al. Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: studies in tPA-deficient mice and wild-type mice on a matched genetic background. Arterioscler Thromb Vasc Biol. 1999;19(11):2801- 2806. (Pubitemid 29536061)
8. Melchor JP, Strickland S. Tissue plasminogen activator in central nervous system physiology and pathology. Thromb Haemost. 2005;93(4):655-660. (Pubitemid 40485400)
9. Samson AL, Medcalf RL. Tissue-type plasminogen activator: a multifaceted modulator of neurotransmission and synaptic plasticity. Neuron. 2006;50(5):673-678.
10. Campbell SJ, Finlay M, Clements JM, et al. Reduction of excitotoxicity and associated leukocyte recruitment by a broad-spectrum matrix metalloproteinase inhibitor. J Neurochem. 2004;89(6):1378-1386. (Pubitemid 38802659)
11. Junge CE, Sugawara T, Mannaioni G, et al. The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia. Proc Natl Acad Sci U S A. 2003;100(22):13019-13024. (Pubitemid 37340018)
12. Li J, Ma Y, Teng YD, et al. Purkinje neuron degeneration in nervous (nr) mutant mice is mediated by a metabolic pathway involving excess tissue plasminogen activator. Proc Natl Acad Sci U S A. 2006;103(20):7847-7852. (Pubitemid 43752869)
13. Sheehan JJ, Zhou C, Gravanis I, et al. Proteolytic activation of monocyte chemoattractant protein-1 by plasmin underlies excitotoxic neurodegeneration in mice. J Neurosci. 2007;27(7):1738-1745. (Pubitemid 46280067)
14. Rogove AD, Siao C, Keyt B, Strickland S, Tsirka SE. Activation of microglia reveals a nonproteolytic cytokine function for tissue plasminogen activator in the central nervous system. J Cell Sci. 1999;112(pt 22):4007-4016. (Pubitemid 30119770)
15. Tsirka SE, Bugge TH, Degen JL, Strickland S. Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin. Proc Natl Acad Sci U S A. 1997;94(18):9779-9781. (Pubitemid 27408140)
16. Tsirka SE, Rogove AD, Bugge TH, Degen JL, Strickland S. An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neuroscience. 1997;17(2):543-552. (Pubitemid 27024567)
17. Aarts M, Liu Y, Liu L, et al. Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions. Science. 2002;298(5594):846-850. (Pubitemid 35231541)
18. Faden AI, Demediuk P, Panter SS, Vink R. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science. 1989;244(4906):798-800. (Pubitemid 19163864)
19. Maas C, Schiks B, Strangi RD, et al. Identification of fibronectin type I domains as amyloid-binding modules on tissue-type plasminogen activator and three homologs. Amyloid. 2008;15(3):166-180.
20. Nolin WB, Emmetsberger J, Bukhari N, Zhang Y, Levine JM, Tsirka SE. tPA-mediated generation of plasmin is catalyzed by the proteoglycan NG2. Glia. 2008;56(2):177-189. (Pubitemid 350292310)
21. Samson AL, Nevin ST, Croucher D, et al. Tissue-type plasminogen activator requires a co-receptor to enhance N-Methyl-D-Aspartate receptor function. J Neurochem. 2008;107(4):1091-1101.
22. Niego B, Horvath A, Coughlin PB, Pugsley MK, Medcalf RL. Desmoteplase-mediated plasminogen activation and clot lysis are inhibited by the lysine analogue tranexamic acid. Blood Coagul Fibrinolysis. 2008;19(4):322-324. (Pubitemid 351670419)
23. Longstaff C, Whitton CM. A proposed reference method for plasminogen activators that enables calculation of enzyme activities in SI units. J Thromb Haemost. 2004;2(8):1416-1421. (Pubitemid 40186140)
24. Soldani C, Scovassi AI. Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update. Apoptosis. 2002;7(4):321-328. (Pubitemid 34832256)
25. Beart PM, Lim ML, Chen B, et al. Hierarchical recruitment by AMPA but not staurosporine of pro-apoptotic mitochondrial signaling in cultured cortical neurons: evidence for caspase-dependent/independent cross-talk. J Neurochem. 2007;103(6):2408-2427. (Pubitemid 350173572)
26. Cheung NS, Pascoe CJ, Giardina SF, John CA, Beart PM. Micromolar L-glutamate induces extensive apoptosis in an apoptotic-necrotic continuum of insult-dependent, excitotoxic injury in cultured cortical neurones. Neuropharmacol. 1998;37(10-11):1419-1429.
27. Narita M, Bu G, Holtzman DM, Schwartz AL. The low-density lipoprotein receptor-related protein, a multifunctional apolipoprotein E receptor, modulates hippocampal neurite development. J Neurochem. 1997;68(2):587-595. (Pubitemid 27044718)
28. Kabakov AE, Gabai VL. Protein aggregation as primary and characteristic cell reaction to various stresses. Experientia. 1993;49(8):706-713.
29. Kingston IB, Castro MJ, Anderson S. In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid beta-peptide analogues. Nat Med. 1995;1(2):138-142.
30. Kranenburg O, Bouma B, Kroon-Batenburg LM, et al. Tissue-type plasminogen activator is a multiligand cross-beta structure receptor. Curr Biol. 2002;12(21):1833-1839. (Pubitemid 35273903)
31. Bacskai BJ, Hickey GA, Skoch J, et al. Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice. Proc Natl Acad Sci U S A. 2003;100(21):12462-12467. (Pubitemid 37271582)
32. Burgos H, Hsi BL, Yeh CJ, Faulk WP. Plasminogen binding by human amniochorion. A possible factor in premature rupture of membranes. Am J Obstet Gynecol. 1982;143(8):958-963. (Pubitemid 12042668)
33. Burtin P, Chavanel G, Andre J. The plasmin system in human colonic tumors: an immunofluorescence study. Int J Cancer. 1985;35(3):307-314. (Pubitemid 15010651)
34. O'Mullane MJ, Baker MS. Loss of cell viability dramatically elevates cell surface plasminogen binding and activation. Exp Cell Res. 1998;242(1):153-164.
35. Ranson M, Andronicos NM, O'Mullane MJ, Baker MS. Increased plasminogen binding is associated with metastatic breast cancer cells: differential expression of plasminogen binding proteins. Br J Cancer. 1998;77(10):1586-1597. (Pubitemid 28230458)
36. Wnendt S, Wetzels I, Gunzler WA. Amyloid beta peptides stimulate tissue-type plasminogen activator but not recombinant prourokinase. Thromb Res. 1997;85(3):217-224. (Pubitemid 27145458)
37. Jacovina AT, Zhong F, Khazanova E, Lev E, Deora AB, Hajjar KA. Neuritogenesis and the nerve growth factor-induced differentiation of PC-12 cells requires annexin II-mediated plasmin generation. J Biol Chem. 2001;276(52):49350-49358. (Pubitemid 37370647)
38. Félez J, Miles LA, Fabregas P, Jardi M, Plow EF, Lijnen RH. Characterization of cellular binding sites and interactive regions within reactants required for enhancement of plasminogen activation by tPA on the surface of leukocytic cells. Thromb Haemost. 1996;76(4):577-584. (Pubitemid 26372014)
39. Mataga N, Mizuguchi Y, Hensch TK. Experience-dependent pruning of dendritic spines in visual cortex by tissue plasminogen activator. Neuron. 2004;44(6):1031-1041. (Pubitemid 39643098)
40. Pang PT, Teng HK, Zaitsev E, et al. Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science. 2004;306(5695):487- 491. (Pubitemid 39372449)
41. Hu BR, Martone ME, Jones YZ, Liu CL. Protein aggregation after transient cerebral ischemia. J Neurosci. 2000;20(9):3191-3199.
42. Ahn MY, Zhang ZG, Tsang W, Chopp M. Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice. Brain Res. 1999;837(1-2):169-176. (Pubitemid 29369228)
43. Burggraf D, Martens HK, Wunderlich N, Jager G, Hamann GF. Rt-PA causes a significant increase in endogenous u-PA during experimental focal cerebral ischemia. Eur J Neurosci. 2004;20(11):2903-2908. (Pubitemid 40007284)
44. Rosenberg GA, Navratil M, Barone F, Feuerstein G. Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab. 1996;16(3):360-366. (Pubitemid 26125324)
45. Yepes M, Sandkvist M, Wong MK, et al. Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. Blood. 2000;96(2):569-576. (Pubitemid 30463377)
46. Wang YF, Tsirka SE, Strickland S, Stieg PE, Soriano SG, Lipton SA. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med. 1998;4(2):228-231. (Pubitemid 28138083)
47. Pfefferkorn T, Staufer B, Liebetrau M, et al. Plasminogen activation in focal cerebral ischemia and reperfusion. J Cereb Blood Flow Metab. 2000;20(2):337-342. (Pubitemid 30108452)
48. Pfefferkorn T, Wiessner C, Allegrini PR, et al. Plasminogen activation in experimental permanent focal cerebral ischemia. Brain Res. 2000;882(1-2):19-25. (Pubitemid 30803699)
49. Zhang Z, Zhang L, Yepes M, et al. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke. Circulation. 2002;106(6):740-745. (Pubitemid 34851936)
50. Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG, Moroy T. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet. 2000;25(2):177-181. (Pubitemid 30394988)
51. Green H. Terminal differentiation of cultured human epidermal cells. Cell. 1977;11(2):405-416. (Pubitemid 8139151)
52. Napirei M, Wulf S, Mannherz HG. Chromatin breakdown during necrosis by serum Dnase1 and the plasminogen system. Arthritis Rheum. 2004;50(6):1873-1883. (Pubitemid 38725100)
53. Zeerleder S, Zwart B, Te Velthuis H, et al. A plasma nucleosome releasing factor (NRF) with serine protease activity is instrumental in removal of nucleosomes from secondary necrotic cells. FEBS Lett. 200727;581(28):5382-5388.
54. Bu C, Zhang C, Li Z, Gao L, Xie Z, Cai G. Autoantibodies to plasminogen and tissue plasminogen activator in women with recurrent pregnancy loss. Clin Exp Immunol. 2007;149(1):31-39. (Pubitemid 46897094)
55. Chen XX, Gu YY, Li SJ, et al. Some plasmin-induced antibodies bind to cardiolipin, display lupus anticoagulant activity and induce fetal loss in mice. J Immunol. 2007;178(8):5351-5356.
56. Chu P, Russell NH, Powell RJ, Cater DR, Harris RJ. Abnormal fibrinolytic activity in systemic lupus erythematosus and possible mechanisms. Br J Rheumatol. 1988;27(6):436-439. (Pubitemid 19028439)
57. Negoro N, Kanayama Y, Takeda T, Fujisawa M, Okamura M, Inoue T. Plasminogen activation in plasma of patients with systemic lupus erythematosus. Rheumatol Int. 1989;8(6):273-277.
58. Gething MJ, Adler B, Boose JA, et al. Variants of human tissue-type plasminogen activator that lack specific structural domains of the heavy chain. EMBO J. 1988;7(9):2731-2740.